| 1 |
31557059 | PML hyposumoylation is responsible for the resistance of pancreatic cancer. | 2019 Nov |
1 |
| 2 |
19808868 | Therapy-induced PML/RARA proteolysis and acute promyelocytic leukemia cure. | 2009 Oct 15 |
2 |
| 3 |
18636556 | PML/RARalpha fusion protein mediates the unique sensitivity to arsenic cytotoxicity in acute promyelocytic leukemia cells: Mechanisms involve the impairment of cAMP signaling and the aberrant regulation of NADPH oxidase. | 2008 Nov |
4 |
| 4 |
15096541 | PML-RARA-RXR oligomers mediate retinoid and rexinoid/cAMP cross-talk in acute promyelocytic leukemia cell differentiation. | 2004 Apr 19 |
7 |
| 5 |
10077561 | Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling. | 1999 Mar 16 |
1 |
| 6 |
8649786 | Differential changes of retinoid-X-receptor (RXR alpha) and its RAR alpha and PML-RAR alpha partners induced by retinoic acid and cAMP distinguish maturation sensitive and resistant t(15;17) promyelocytic leukemia NB4 cells. | 1996 Jun 6 |
2 |
| 7 |
8649787 | cAMP signalling is decisive for recovery of nuclear bodies (PODs) during maturation of RA-resistant t(15;17) promyelocytic leukemia NB4 cells expressing PML-RAR alpha. | 1996 Jun 6 |
1 |